Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Researchers found no significant differences in surgical outcomes or follow-up between housed and unhoused patients with ...

Johnson & Johnson MedTech (NYSE:JNJ) today announced a strategic co-promotion agreement with Pacira BioSciences.

Osteoarthritis (OA) is a painful, progressive and widespread joint disease that affects at least one in four adult dogs – and ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

HealthDay News — Patients with osteoporosis who suffer a fragility fracture at age 80 years or older have better 5-year outcomes if they receive treatment for osteoporosis, according to a study ...

CHICO, Calif. - Arthritis is a leading reason for euthanizing older pets, but a new treatment called Synovetin OA is offering hope to pet owners. This breakthrough is promising to change the lives of ...

Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access ...

You’re considering new options for managing chronic pain, and PRP injections might just offer the relief you’re seeking. This innovative therapy taps into your body’s natural healing power, offering ...

Romosozumab, used in osteoporosis treatment, may offer dual benefits by also reducing the risk for osteoarthritis, notably ...

Study in Frontiers in Veterinary Science finds investigational plasmid Elenagen cut osteoarthritis pain by 50 % in dogs and ...